Search Results 2171-2180 of 16222 for Epilepsy (Partial Onset)

  1. A Study to Evaluate The Effectiveness and Safety of Abrocitinib, with or without Topical Medications, in Subjects Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    Female subjects of childbearing potential must agree to use a highly effective method of contraception for the duration ... early in a qualifying Parent ...

  2. Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation - Mayo Clinic

    Anticipated cold ischemia time <12 hours (excluding HOPE duration) - Functional warm ischemia time ≤35 minutes, defined as interval from the time of onset

  3. Emicizumab in Patients With Acquired Hemophilia A - Mayo Clinic

    ... partial remission and remained significant after adjustment for baseline demographic and clinical characteristics. ... Recent onset of bleeds and isolated ...

  4. Moyamoya disease - Doctors and departments - Mayo Clinic

    Meyer, M.D.. Neurosurgeon. Rochester, MN. Areas of focus: Epilepsy surgery, Brain tumor surgery, Awake brain surgery, Pituitary tumor surgery, Trigeminal ...

  5. Intravenous Ketamine for Treatment-Resistant Depression (G2K) - Mayo Clinic

    ... partial) and sustained (> 1 year) remission; History of traumatic brain injury that resulted in loss of consciousness; History of tonic-clonic (grand mal) ...

  6. Peripheral Neuropathy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to collect skin biopsies from patients who have known cases of chemotherapy induced peripheral neuropathy and analyze the samples ...

  7. A Study to Evaluate Pembrolizumab Combined with Intensive Chemotherapy to Treat Patients with Acute Myeloid Leukemia - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... partial thromboplastin time (PTT) is within ... duration of the trial, or ...

  8. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Confirmed COVID-19: the Baseline visit must be at least 14 days from onset of signs/symptoms or positive SARS-CoV-2 test, symptomatic subjects must have ...

  9. Narcolepsy Clinical Trials - Mayo Clinic Research

    A Study of Childhood Onset Narcolepsy Rochester, MN. The purpose of this study is to evaluate the clinical presentations, polysomnographic features, ...

  10. A Study to Map White Matter Cognitive Functions Using Stereo EEG - Mayo Clinic

    Undergoing stereo EEG for localization of epilepsy will be recruited. English speaking. Exclusion Criteria: Patients under the age of 18. Non-English ...